|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/60 | (2017.01) |
| C07K 14/47 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2563400 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11716429.3 |
| Date of filing the European patent application | 2011-04-29 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation | 2019-10-10 |
| (86) | Number | PCT/EP2011/056824 |
| Date | 2011-04-29 |
| (87) | Number | WO 2011/135067 |
| Date | 2011-11-03 |
| (30) | Number | Date | Country code |
| 10161685 | 2010-04-30 | EP |
| (72) |
BINZ, Hans Kaspar, CH
FORRER, Patrik, CH
STUMPP, Michael Tobias, CH
|
| (73) |
Molecular Partners AG,
Wagistrasse 14, 8952 Schlieren,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoti surišantys baltymai, slopinantys VEGF-A receptoriaus sąveiką |
| Modified binding proteins inhibiting the VEGF-A receptor interaction |
| Payment date | Validity (years) | Amount | |
| 2024-03-27 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-04-29 |